Skip to main content
Log in

Preliminary pharmacokinetic and pharmacodynamic studies on flunixin meglumine in donkeys

  • Short Communication
  • Published:
Veterinary Research Communications Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abbreviations

AUC:

area under the curve

ClB :

body clearance

FM:

flunixin meglumine

HETE:

hydroxyeicosatetraenoic acid

HPLC:

high-performance liquid chromatography

MRT:

mean residence time

PG:

prostaglandin

RIA:

radioimmunoassay

t 1/2 β :

elimination half-life

TX:

thromboxane

Vss :

apparent volume of distribution

References

  • Anderson, D., 1988. Clinical use of flunixin. British Veterinary Journal, Supplement 1, 7–8

    Google Scholar 

  • Higgins A.J. and Lees P., 1984. Arachidonic acid metabolites in carrageenan-induced equine inflammatory exudate. Journal of Veterinary Pharmacology and Therapeutics, 7, 65–72

    Google Scholar 

  • Higgins A.J., Lees P. and Sedgwick A.D., 1987. Development of equine models of inflammation. Veterinary Record, 120, 517–522.

    Google Scholar 

  • Kopcha M. and Ahl A.S., 1989. Experimental uses of flunixin meglumine and phenylbutazone in food producing animals. Journal of the American Veterinary Medical Association, 194, 45–49

    Google Scholar 

  • Landoni M.F., Cunningham F.M. and Lees P., 1995. Determination of pharmacokinetics and pharmacodynamics of flunixin in calves by use of pharmacokinetic/pharmacodynamic modeling. American Journal of Veterinary Research, 56, 786–794

    Google Scholar 

  • Lees P., Higgins A.J., Sedgwick A.D. and May S.A., 1987a. Applications of equine models of acute inflammation. Veterinary Record, 120, 522–529

    Google Scholar 

  • Lees P., Ewins C.P., Taylor B.O. and Sedgwick A.D., 1987b. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin. British Veterinary Journal, 143, 462–476

    Google Scholar 

  • McKellar Q.A., Galbraith E.A., Bogan J.A., Russell C.S., Hooke R.E. and Lees P., 1989. Flunixin pharmacokinetics and serum thromboxane inhibition in the dog. Veterinary Record, 124, 651–654

    Google Scholar 

  • McKellar Q.A., Lees P. and Gettinby G., 1994. Pharmacodynamics of tolfenamic acid in dogs. Evaluation of dose-response relationships. European Journal of Pharmacology, 253, 191–200

    Google Scholar 

  • Selman, I., 1988. Experimental studies with flunixin meglumine. British Veterinary Journal, Supplement 1, 4–6

    Google Scholar 

  • Semrad S.D., Hardee G.E., Hardee M.M. and Moore J.N., 1985. Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses. American Journal of Veterinary Research, 46, 2474–2497

    Google Scholar 

  • Taylor P.M., Winnard J.G. and Lees P., 1994. Flunixin in the cat: a pharmacokinetic and toxicological study. British Veterinary Journal, 150, 253–262

    Google Scholar 

  • Welsh E.M., McKellar Q.A. and Nolan A.M., 1993. The pharmacokinetics of flunixin meglumine in the sheep. Journal of Veterinary Pharmacology and Therapeutics, 16, 181–188

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheng, Z., McKellar, Q., Nolan, A. et al. Preliminary pharmacokinetic and pharmacodynamic studies on flunixin meglumine in donkeys. Vet Res Commun 20, 469–472 (1996). https://doi.org/10.1007/BF00419184

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00419184

Keywords

Navigation